{"id":418,"date":"2014-07-16T14:25:32","date_gmt":"2014-07-16T14:25:32","guid":{"rendered":"https:\/\/blogs.bmj.com\/jnnp\/?p=418"},"modified":"2014-07-16T14:25:32","modified_gmt":"2014-07-16T14:25:32","slug":"pregnancy-and-ms-the-need-to-commence-treatment-post-partum","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/jnnp\/2014\/07\/16\/pregnancy-and-ms-the-need-to-commence-treatment-post-partum\/","title":{"rendered":"Pregnancy and MS. The need to commence treatment post-partum?"},"content":{"rendered":"

While pregnancy is associated with a reduced risk of relapses, caution is required in the post-partum period.\u00a0 In this issue of JNNP, Portaccio and colleagues elegantly demonstrate an increased risk of relapse in the post-partum period. \u00a0 Greater disease activity before and during pregnancy were reported as predictors of an increased chance of a relapse in the post-partum period.\u00a0 Therapy with DMDs in the immediate post-partum period seemed to reduced risk of future relapse.<\/p>\n

 <\/p>\n

Read more at http:\/\/jnnp.bmj.com\/content\/85\/8\/845.abstract<\/p>\n

 <\/p>\n

Neurol Neurosurg Psychiatry<\/abbr> <\/span> 2014;<\/span>85:<\/span><\/span>845-850 <\/span> doi:10.1136\/jnnp-2013-306054 <\/span> <\/cite><\/div>\n